Literature DB >> 25820260

Determination of Flurbiprofen in Human Plasma by High-Performance Liquid Chromatography.

Bilal Yilmaz1, Ali Fuat Erdem2.   

Abstract

A simple high-performance liquid chromatography method has been developed for determination of flurbiprofen in human plasma. The method was validated on an Ace C18 column using UV detection. The mobile phase was acetonitrile-0.05 M potassium dihydrogen phosphate solution (60:40, v/v) adjusted to pH 3.5 with phosphoric acid. The calibration curve was linear between the concentration range of 0.10-5.0 μg/mL. Intra- and inter-day precision values for flurbiprofen in plasma were <4.47, and accuracy (relative error) was better than 3.67%. The extraction recoveries of flurbiprofen from human plasma were between 93.0 and 98.9%. The limits of detection and quantification of flurbiprofen were 0.03 and 0.10 μg/mL, respectively. In addition, this assay was applied to determine the pharmacokinetic parameters of flurbiprofen in six healthy Turkish volunteers who had been given 100 mg flurbiprofen.
© The Author 2015. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25820260     DOI: 10.1093/chromsci/bmv032

Source DB:  PubMed          Journal:  J Chromatogr Sci        ISSN: 0021-9665            Impact factor:   1.618


  3 in total

1.  Determination of the Permeation and Penetration of Flurbiprofen into Cadaveric Human Pharynx Tissue.

Authors:  Rob Turner; Sean Robert Wevrett; Suzanne Edmunds; Marc B Brown; Robert Atkinson; Oluwajoba Adegoke; Anuradha Kulasekaran; Tim Shea
Journal:  Clin Pharmacol       Date:  2020-03-24

2.  Validation of an analytical method to quantify the permeation and penetration of flurbiprofen into human pharynx tissue.

Authors:  Rob Turner; Sean Robert Wevrett; Suzanne Edmunds; Marc Brown; Robert Atkinson; Tim Shea
Journal:  Biomed Chromatogr       Date:  2019-05-06       Impact factor: 1.902

Review 3.  Organic solute carrier 22 (SLC22) family: Potential for interactions with food, herbal/dietary supplements, endogenous compounds, and drugs.

Authors:  Raymond E Lai; Christopher E Jay; Douglas H Sweet
Journal:  J Food Drug Anal       Date:  2018-03-24       Impact factor: 6.157

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.